Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

363
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
363
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

868
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
868

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bi- and Mono-Allelic RFC1 Expansion in a North American Cohort With Idiopathic Axonal Neuropathy.

Annals of clinical and translational neurology·2026
Same author

Guillain-Barré syndrome following intracranial hemorrhage: a systematic review of case reports.

Frontiers in neurology·2026
Same author

Message From the Editors to Our Reviewers.

Neurology·2026
Same author

Comparing In-Person to Tele-Exercise High-Intensity Interval Training in Adults With Class II/III Obesity.

AACE endocrinology and diabetes·2026
Same author

Metabolic and Microvascular Risk Factors Associated With Brain Health in Type 1 Diabetes.

Annals of clinical and translational neurology·2026
Same author

Diabetic Peripheral Neuropathy May Be an Independent Risk Marker for Dementia and Cerebrovascular Disease.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: Jan 16, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.3K

Atypical diabetic neuropathies.

Brett A McCray1, Amro M Stino1, Long Davalos2

  • 1Department of Neurology, University of Michigan, Ann Arbor, MI, USA.

BMJ (Clinical Research Ed.)
|September 29, 2025
PubMed
Summary
This summary is machine-generated.

Diabetic neuropathy encompasses more than typical nerve damage. This review details atypical conditions like treatment-induced neuropathy, radiculoplexus neuropathies, and chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetic patients.

More Related Videos

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.0K
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

13.7K

Related Experiment Videos

Last Updated: Jan 16, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.3K
Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
09:39

Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1

Published on: February 13, 2018

10.0K
Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies
11:22

Three-dimensional Imaging of Nociceptive Intraepidermal Nerve Fibers in Human Skin Biopsies

Published on: April 29, 2013

13.7K

Area of Science:

  • Neurology
  • Endocrinology
  • Diabetology

Background:

  • Diabetes mellitus is a global health issue with diverse systemic complications.
  • Diabetic polyneuropathy affects approximately 50% of patients, but atypical forms are also prevalent.
  • Understanding these varied neuropathies is crucial for effective patient management.

Purpose of the Study:

  • To review and discuss atypical peripheral nerve conditions associated with diabetes.
  • To differentiate these neuropathies from typical diabetic polyneuropathy.
  • To provide insights into their underlying mechanisms and clinical presentations.

Main Methods:

  • Literature review of atypical diabetic neuropathies.
  • Analysis of clinical presentations, pathophysiology, and diagnostic challenges.
  • Synthesis of current evidence on treatment-induced neuropathy, radiculoplexus neuropathies, cranial mononeuropathies, compressive neuropathies, and CIDP in diabetes.

Main Results:

  • Identified several atypical neuropathies including treatment-induced, radiculoplexus, cranial mononeuropathies, compressive neuropathies, and CIDP.
  • Highlighted distinct pathophysiological mechanisms: microvasculitis, ischemia, and compression.
  • Noted diagnostic challenges, especially for CIDP in diabetic individuals.

Conclusions:

  • Diabetic patients are susceptible to a spectrum of neuropathies beyond typical distal symmetric polyneuropathy.
  • Atypical neuropathies present with varied mechanisms and clinical courses.
  • Further research and diagnostic refinement are needed for optimal care of these complex conditions.